AUSTEDO® XR: Tardive Dyskinesia and Huntingtons Chorea Treatment AUSTEDO® XR (deutetrabenazine) extended-release tablets is the first medication approved to treat both tardive dyskinesia and Huntington's disease chorea See safety info including Boxed Warning
AUSTEDO XR® Medication for Tardive Dyskinesia (TD) Once-daily AUSTEDO XR® (deutetrabenazine) extended release tablets reduce uncontrollable Tardive Dyskinesia (TD) body movements See safety info including Boxed Warning
AUS-47312 XR HD:TD AUSTEDO Prescribing Information Digitial v6 AUSTEDO XR and AUSTEDO can increase the risk of depression and suicidal thoughts and behavior (suicidality) in patients with Huntington’s disease Anyone considering the use of AUSTEDO XR or AUSTEDO must balance the risks of depression and suicidality with the clinical need for treatment of chorea
AUS-47311 AUSTEDO and AUSTEDO XR Medication Guide Digital v3 AUSTEDO XR and AUSTEDO are prescription medicines that are used to treat: • the involuntary movements (chorea) of Huntington’s disease AUSTEDO XR and AUSTEDO do not cure the cause of the involuntary movements, and it does not treat other symptoms of Huntington’s disease, such as problems with thinking or emotions
AUSTEDO XR® Dosing for Tardive Dyskinesia Learn about once-daily dosages for AUSTEDO XR® (deutetrabenazine) extended-release tablets to help relieve Tardive Dyskinesia (TD) See safety info and Boxed Warning
Patient Support Program | AUSTEDO XR® (deutetrabenazine) More than 90% of people pay $10 or less per month for AUSTEDO XR ‡ Patients can start AUSTEDO XR for $0 with a 30-day Free Trial Voucher Additional financial assistance options are available for eligible patients Certain restrictions apply Terms and conditions on AUSTEDOcardform com